Pharmacokinetics of rifabutin in Japanese HIV-infected patients with or without antiretroviral therapy.

Pharmacokinetics of rifabutin in Japanese HIV-infected patients with or without antiretroviral therapy.

OBJECTIVE: Based on drug-drug interaction, dose reduction of rifabutin is recommended when co-administered with HIV protease inhibitors for human immunodeficiency virus (HIV)-associated mycobacterial infection. The aim of this study was to compare the pharmacokinetics of rifabutin administered at 30...

Full description

Bibliographic Details
Main Authors: Junko Tanuma, Kazumi Sano, Katsuji Teruya, Koji Watanabe, Takahiro Aoki, Haruhito Honda, Hirohisa Yazaki, Kunihisa Tsukada, Hiroyuki Gatanaga, Yoshimi Kikuchi, Shinichi Oka
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3734254?pdf=render

Internet

http://europepmc.org/articles/PMC3734254?pdf=render

Similar Items